Brief: Vivos Therapeutics To Begin Clinical Trial At Stanford Medicine
11/10/2023 12:33
Oct 11 (Reuters) - Vivos Therapeutics Inc VVOS.O :
* VIVOS THERAPEUTICS TO BEGIN CLINICAL TRIAL AT STANFORD
MEDICINE
* VIVOS THERAPEUTICS INC - PROTOCOL HAS BEEN FINALIZED AND
PARTICIPANT ENROLLMENT WILL BEGIN IN EARLY 2024
Source text for Eikon: ID:nGNX8zXDy
Further company coverage: VVOS.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Vivos Therapeutics
See all newsBrief: Vivos Therapeutics Closes Acquisition Of Stake In Sod Sciences And 50% Interest In Pseudohypoxia Test, Opening A Potential Path To Access More Than 325,000 New Patients Through The Aha Channel
Brief: Vivos Therapeutics - Audit Reports For Fy2025 And Fy2024 Include Substantial Doubt About Going Concern
Brief: Vivos Therapeutics And South Palm Cardiovascular Associates Sign Definitive Agreements To Launch Regional Sleep Testing And Treatment Center
Vivos Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Vivos Therapeutics Q2 revenue rises 35% on service growth